Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.

Summary

The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).

Conditions

• Stress Disorder

Interventions

DIAGNOSTIC_TEST

Generalized Anxiety Disorder-7 (GAD 7)

test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry.

DIAGNOSTIC_TEST

Background questionnaire

questionnaire on the living conditions, socio-professional contexts and environmental conditions of the participants

DIAGNOSTIC_TEST

Impact of COVID-19 questionnaire

status of the patient with regard to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus)

DIAGNOSTIC_TEST

Confinement and Communication During the COVID-19 Pandemic

know the experience of containment and isolation during the pandemic

DIAGNOSTIC_TEST

Mental Health questionnaire

welfare effect

DIAGNOSTIC_TEST

Patient Health Questionnaire (PHQ-9)

assess depression during the pandemic

DIAGNOSTIC_TEST

Post Traumatic Stress Disorder questionnaire (PTSD-8)

Assessing the trauma of subjects during the pandemic

DIAGNOSTIC_TEST

Experiences in Close Relationship Scale questionnaire (ECR-S)

Measuring social ties and attachment of subjects

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Saint Etienne

  lead OTHER

Principal Investigators

• Claude LAMBERT, MD PhD HDR · CHU SAINT-ETIENNE

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-10-22

Primary Completion

2021-09-29

Completion

2021-09-29

Countries

• France
• United Kingdom

Study Locations